The EMCDDA offers an overview on naloxone access in the European Union and summarises the effectiveness of hand-out naloxone programmes to save the lives of people at risk of overdosing as well as giving recommendations for the future.

The EU provides a unique insight into the operation of illicit drug markets in the region.

The EU outlines its priorities in relation to drug markets for the next four years.